TP53 and myelodysplastic syndrome: Among patients with TP53 mutations, the frequencies of complex karyotypes and multi-hit TP53 mutations were significantly higher in the MDS-E group than in the MDS-NE group(87.5% vs 64.6%, P=0.003 and 84.0% vs 54.2%, P<0.001, respectively).